Back
Edgewise Therapeutics Stock Price Chart
Buy
53
EWTX
Edgewise Therapeutics
Last Price:
16.72
Seasonality Move:
-4.2%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing selling pressure, which indicates risk of future bearish movement.
Edgewise Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.22 | Sell |
| 20-day SMA: | 17.32 | Sell |
| 50-day SMA: | 17.5 | Sell |
| 200-day SMA: | 12.68 | Buy |
| 8-day EMA: | 17.11 | Sell |
| 20-day EMA: | 17.37 | Sell |
| 50-day EMA: | 17.36 | Sell |
| 200-day EMA: | 14.14 | Buy |
Edgewise Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 46.46 | Sell |
| Chaikin Money Flow: | -676466 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.97 - 18.03) | Sell |
| Bollinger Bands (100): | (16.29 - 18.69) | Sell |
Edgewise Therapeutics Technical Analysis
| Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Edgewise Therapeutics Stock
Is Edgewise Therapeutics Stock a Buy?
- Edgewise Therapeutics share price is 17.05 while EWTX 8-day simple moving average is 17.22, which is a Sell signal.
- The stock price of EWTX is 17.05 while Edgewise Therapeutics 20-day SMA is 17.32, which makes it a Sell.
- Edgewise Therapeutics 50-day simple moving average is 17.50 while EWTX share price is 17.05, making it a Sell technically.
- EWTX stock price is 17.05 and Edgewise Therapeutics 200-day simple moving average is 12.68, creating a Buy signal.
EWTX Technical Analysis vs Fundamental Analysis
Buy
53
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy or a Sell?
-
Edgewise Therapeutics stock is rated a Buy
The current Edgewise Therapeutics [EWTX] share price is $17.05. The Score for EWTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Edgewise Therapeutics Stock Info
Market Cap:
1.59B
Price in USD:
17.05
Share Volume:
757.24K
Edgewise Therapeutics 52-Week Range
52-Week High:
21.60
52-Week Low:
5.12
Buy
53
Edgewise Therapeutics (EWTX)
is a Buy
Edgewise Therapeutics Share Price Forecast
-
What is the Edgewise Therapeutics stock price today?
The Edgewise Therapeutics stock price is 17.05 USD today. -
Will EWTX stock go up or go down?
Edgewise Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Edgewise Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Edgewise Therapeutics is not overvalued.
Is Edgewise Therapeutics Stock a Buy?
- Edgewise Therapeutics share price is 17.05 while EWTX 8-day exponential moving average is 17.11, which is a Sell signal.
- The stock price of EWTX is 17.05 while Edgewise Therapeutics 20-day EMA is 17.37, which makes it a Sell.
- Edgewise Therapeutics 50-day exponential moving average is 17.36 while EWTX share price is 17.05, making it a Sell technically.
- EWTX stock price is 17.05 and Edgewise Therapeutics 200-day simple moving average is 14.14, creating a Buy signal.
Fundamental Analysis of Edgewise Therapeutics
Is Edgewise Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.39 per share.
Technical Analysis of Edgewise Therapeutics
Should I short Edgewise Therapeutics stock?
- EWTX Moving Average Covergence Divergence (MACD) indicator is -0.21, suggesting Edgewise Therapeutics is a Sell
- Edgewise Therapeutics Relative Strength Index (RSI) is 46.46, which suggest Edgewise Therapeutics is oversold
- The Bollinger Bands (25) for Edgewise Therapeutics is (16.97 - 18.03), which suggest Edgewise Therapeutics is a Sell
- The Bollinger Bands (100) for Edgewise Therapeutics is (16.29 - 18.69), which suggest Edgewise Therapeutics is a Sell
* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.